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Doxepin is a tricyclic antidepressant (TCA) and has been
widely used in the treatment of major depression and other
psychiatric disorders [1]. Recently, doxepin and other TCAs
have also been found to be effective in the treatment of
various acute and chronic painful conditions, including
postoperative pain, low back pain, and neuropathic pain
[2–6]. Doxepin, like other TCAs, exerts its action through
several mechanisms, such as blockade of α2-adrenergic,
N-methyl-D-aspartate, and histaminergic H2 receptors, and
inhibition of the reuptake of serotonin and norepinephrine
[2–7]. Doxepin has also recently been found to be effective
in blocking the use-dependent and voltage-gated Na+
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channels [8,9]. This phenomenon of Na+ channel blockade
was also found with local anesthetics in clinical use [10].
Following perisciatic nerve injection, doxepin further
produced a significant neural blockade on the sciatic nerve
[9,11]. Following intrathecal injection, doxepin also
produced a significant spinal anesthetic effect in a single-
dose study [12]. These important results suggested that
doxepin has a local anesthetic effect. However, although
several workers suggested that doxepin has a local anesthetic
effect, studies related to its spinal action have been relatively
inconclusive. First, no dose-response study was carried out
to evaluate the spinal action of doxepin. Second, no duration
study was carried out to evaluate the duration of its action.
Third, no comparisons were made between doxepin and
the traditional local anesthetics on their potencies and
duration of action. The aim of our study was to evaluate and
compare the potency and duration of the spinal anesthetic
effect of doxepin with two commonly used traditional local
anesthetics, bupivacaine and lidocaine.
© 2006 Elsevier. All rights reserved.
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MATERIALS AND METHODS
Male Sprague-Dawley rats, obtained from the National
Laboratory Animal Center, Taiwan (weight between 300
and 350 g), were used. They were housed in groups of three
for at least 1 week in a climate-controlled room maintained
at 21°C with approximately 50% relative humidity. Lighting
was on a 12-hour light/dark cycle (lights on at 6:00 a.m.),
with food and water available on demand except during the
time of testing. Each treatment group (that is, for each drug
of each dose) consisted of six rats. All tests were performed
in accordance with the recommendations and policies of the
International Association for the Study of Pain, and the
protocol was approved by the animal investigation
committee of Chi-Mei Medical Center.
In part 1 of the study, the potencies of doxepin,
bupivacaine, and lidocaine were evaluated for their spinal
anesthetic effect. Part 2 evaluated the durations of their
spinal anesthetic effect.
Doxepin HCl, bupivacaine HCl, and lidocaine HCl were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
All drugs were dissolved in 5% dextrose as a solution. Rats
were handled before testing to familiarize them with the
experiment and to minimize stress-induced analgesia. The
experimenter was blinded to the drugs and dosages used.
Intrathecal injections of drugs were performed according to
the method reported previously [12]. In brief, the injections
of drugs were performed in conscious rats following
adequate local anesthesia by infiltration with 1.0% lidocaine
(50 µL) around the injection site of lumbar intervertebral
space 4 to 5 (L4–5). Following local infiltrative anesthesia, a
27-gauge needle attached to a 100-µL syringe (Hamilton,
Reno, NV, USA) was inserted intrathecally through the
midline of the L4–5 intervertebral space and 90 µL of drug
was instilled. Success in intrathecal injection was confirmed
by a sense of ‘give’ and the sign of a tail flick [12,13]. Each
rat received only one intrathecal injection of drug.
In part 1, the potencies of the drugs’ action were
evaluated. Following intrathecal injections of drugs (n = 6
rats for each drug of each dose), three neurobehavioral
examinations that evaluated motor function, proprioception,
and nociception were conducted according to the method
reported previously [11,12]. Briefly, (1) motor function was
evaluated by measuring the strength of extensor postural
thrust of the hindlimbs of rats, (2) proprioception was
evaluated by measuring the functional deficit of a hopping
response following waving the animal body while it
was standing on just one hindlimb, and (3) nociception
was evaluated by measuring the withdrawal reflex or
vocalization elicited by pinches of the skinfold over the
back 1 cm from the proximal part of the tail, the lateral
metatarsus of the bilateral hindlimbs, and the dorsal part of
the mid-tail. Rats were tested at 5 minutes before medication,
at 1, 5, and 10 minutes afterward, again at 10-minute intervals
until 1 hour had passed, and at 15-minute intervals until 2
hours had passed. For consistency, one trained examiner
was responsible for all rat handling and behavioral
evaluations. The magnitude of spinal blockade (motor
function, proprioception, and nociception) was described
as the percentage of possible effect (% PE) [12]; the maximum
value of % PE values following each test was presented as
percentage of maximum possible effect (% MPE). Dose-
response curves were constructed following tests, and the
50% effective doses (ED50 values) of the drugs were then
obtained from computer-derived curve fitting by SAS NLIN
analysis (SAS Institute Inc., Cary, NC, USA) of the dose-
response curves. The ED50 was defined as the dose of a
drug that caused a 50% spinal block of motor function,
proprioception, or nociception following intrathecal
administration [14].
In part 2, the durations of the drugs’ action were
evaluated. The ED25 and ED75 values of drugs were obtained
from computer-derived curve fitting as described in part 1.
Rats then received intrathecal injections of drug at doses of
ED25, ED50, or ED75 (n = 6 rats for each drug of each dose).
However, because there were three ED50 values for each
drug (that is, ED50 values for motor function, proprioception,
and nociception), the mean value of these three ED50
values was used for injection. The mean values of ED25
and ED75 were also obtained by the above method. The
duration of the spinal anesthetic effect of drug was defined
as the full recovery time of spinal blockade. It was measured
as an interval from time zero at the time of injection to the
time of complete recovery [11,12].
The differences of ED50 values among drugs were
evaluated by using a one-way analysis of variance (ANOVA)
followed by the pairwise Tukey HSD test. The differences of
duration among drugs were evaluated by a two-way
ANOVA followed by the pairwise Tukey HSD test. Statistical
significance was defined as p < 0.05.
RESULTS
The effects in rat spinal blockade in motor function,
proprioception, and nociception of doxepin and two
traditional local anesthetics at various doses were evaluated.
Because of the similarities of the values, only those obtained
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from doxepin and bupivacaine at an administered dose of
0.45 µmol are shown (Figure 1). At this dose, doxepin
provided 81.1%, 84.8%, and 75.0% of blockades (% MPE)
in motor function, proprioception, and nociception,
respectively, whereas bupivacaine provided 74.2%, 75.2%,
and 70.8% of blockades, respectively.
The dose-response curves were constructed following
intrathecal injections of drugs of different doses (Figure 2).
The ED50 values of drugs for the spinal blockades of motor
function, proprioception, and nociception are given in the
Table. Doxepin, bupivacaine, and lidocaine produced dose-
related spinal blockades of motor function, propioception,
and nociception. The potency of spinal blockade by doxepin
was similar to that of bupivacaine and higher than that of
lidocaine (Table). All rats recovered completely after
intrathecal injections of drugs. The durations of spinal
blockades of drugs are shown in Figure 3. Among the
drugs evaluated, doxepin had the longest duration of
action (p < 0.001, in motor function, proprioception, and
nociception).
DISCUSSION
In this study, the potencies and durations of the spinal
anesthetic effects of doxepin and two traditional local
anesthetics were evaluated and compared. We found that
doxepin produced dose-related spinal anesthetic effects of
motor function, proprioception, and nociception that were
more potent than those of lidocaine and longer lasting than
those of bupivacaine and lidocaine.
Doxepin, a TCA, has been used in the treatment of major
depression and other psychiatric disorders for longer than
40 years [1]. Recently, doxepin and other TCAs have also
been used in the treatment of pain [2–6,15,16]. In animal
studies, doxepin dose-dependently increased the mechanical
pain threshold of the paw in rats [6]. Doxepin given 30
minutes before intraplantar formalin also significantly
increased the inflammatory pain threshold of the paw in
rats [6]. In human studies, doxepin administered
preoperatively significantly decreased postoperative
opioid requirements [6]. Doxepin also effectively relieved
lower back pain and neuropathic pain in patients [15,16].
Although doxepin was effective in alleviating pain, the
detailed mechanism of its action is not clear [2]. The proposed
mechanism was that doxepin, a TCA, might enhance the
inhibitory descending cortical, supraspinal, and spinal
pathways that might mitigate nociceptive impulses from
the peripheral to the central nervous system [2–6]. This
mechanism might involve the inhibition of the reuptake of
serotonin and norepinephrine, and the blockade of the
muscarinic, cholinergic, histaminergic, α2-adrenergic,
N-methyl-D-aspartate receptors [2–6]. Recently, doxepin
and several other TCAs were also found to have a blocking
effect on Na+ conductance by a manner similar to the
clinically used local anesthetics [10,12,14]. However,
although doxepin appeared to have a local anesthetic
effect, studies related to the spinal anesthetic effect of
doxepin were relatively inconclusive. Here, we demonstrate
that doxepin, acting as a local anesthetic, dose-dependently
blocked the spinal functions of motor activity,
proprioception, and nociception. In comparison with
bupivacaine, a potent and long-acting traditional local
anesthetic, doxepin produced an equipotent local anesthetic
effect but with longer duration of action. This result was
valuable, not only pharmacologically, but also clinically. If
doxepin is appropriately used, its specific characteristics
may further enhance its clinical value in the management of
pain. The spinal actions of doxepin may also give some
explanations of its clinical effect in pain management.
Table. ED50 values with 95% CI of spinal blockade of doxepin, bupivacaine, and lidocaine following intrathecal injections in rats
Motor function Proprioception Nociception Mean
Drugs ED50 (95% CI) ED50 (95% CI) ED50 (95% CI) ED50
Doxepin 0.32 (0.30–0.35)* 0.30 (0.27–0.33)* 0.32 (0.29–0.36)* 0.31
Bupivacaine 0.36 (0.34–0.38) 0.35 (0.33–0.37) 0.35 (0.33–0.37) 0.35
Lidocaine 1.33 (1.27–1.38) 1.29 (1.21–1.38) 1.19 (1.12–1.26) 1.27
CI = confidence interval.
ED50 values (µmol) of drugs tested were obtained from computer-derived curve fitting by SAS NLIN analysis of the dose-response curves shown
in Figure 2. *p < 0.001 when compared with lidocaine, by using a one-way ANOVA followed by the pairwise Tukey HSD test. The difference
between doxepin and bupivacaine was not significant.
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Figure 2. The dose-response curves of spinal blockade of doxepin (D),
bupivacaine (B), and lidocaine (L) following intrathecal injections in
rats (n = 6 for each drug of each dose). Data (mean ± SE) were fitted by
SAS NLIN analysis.
Figure 1. The effects of spinal blockade (percentage of possible effect, %
PE) of doxepin and bupivacaine (mean ± SE) in rats (n = 6 in each
group). The injected dose was 0.45 mmol. Neurologic evaluation was
obtained before, and at 1, 5, 10, 20, 30, 40, 50, 60, 75, and 90 minutes
after drug injection.
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CONCLUSIONS
Intrathecal doxepin produced dose-related spinal anesthetic
effects of motor function, proprioception and nociception
that were more potent than that of lidocaine and longer than
that of bupivacaine and lidocaine. The spinal actions of
doxepin may provide some explanation of its clinical effect
in pain management.
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